Developer docs
API playgroundTry for free, no card

Search company profiles

Neolytica

Full company profile

uuid000hc7l

Namestring
Neolytica
Legal namestring
Neolytica
Websiteurl
neolytica.ai
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Neolytica is a privately held healthcare analytics company that builds AI-driven KOL mapping, HCP engagement, and sentiment analysis software for pharmaceutical and life sciences clients. Founded in March 2022 as a subsidiary of QPharma (established 1994) and headquartered in Morristown, NJ, the company sells two core products under the Ti Expert and NotifyMe brands, plus a Ti Risk module for opioid diversion detection. The platform combines AI/NLP processing of publications, clinical trials, conference proceedings, and social media across 100,000+ digital sources with human review by 300+ medical experts to deliver customized (not syndicated) expert databases, influence mapping, gap and landscape analyses, and a Next Best Dialogue recommendation layer that suggests personalized engagement actions.

Underlying technology spans text NLP, structured claims/Rx analysis, and multimodal expert-profile aggregation. Capabilities include sentiment tagging (Positive/Neutral/Negative), predictive identification of rising-star and bridge-builder KOLs, Influencer Relationship Management with automated compliance workflows, and multi-source social listening via the NotifyMe alerting service. Operations run across the US and India, and the platform already monitors data sources in markets including China. Neolytica monetizes through annual subscription enterprise SaaS contracts sold via direct field sales, with quote-based pricing not publicly disclosed.

The company targets Medical Affairs, Market Access, Commercial Marketing, and Commercial Sales teams within pharmaceutical organizations, and claims 12 of the top 20 pharmaceutical companies as customers. The single-team platform includes compliance firewalls separating Medical and Marketing use, addressing pharma's regulatory constraints. Leadership is anchored by Founder and President Badal Shah, who previously built the KOL mapping business at Veeva Systems. The firm has received recognition including Silicon India 'Most Promising Company' and IFAH Top 100 Healthcare Leader. No external funding rounds are disclosed, consistent with its operating-subsidiary status under QPharma.

Short descriptiontext

Neolytica is an AI-driven healthcare analytics subsidiary of QPharma that sells enterprise SaaS for KOL mapping, HCP engagement, and expert-validated sentiment analysis to pharmaceutical Medical Affairs and Commercial teams.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMorristown, United States
HQ citystring
Morristown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
KOL mapping software, HCP engagement platform, pharmaceutical analytics, sentiment analysis, healthcare AI platform
Industry1 code
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare Analytics / Pharmaceutical KOL Intelligence Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Platform Subscriptions
TypeSubscription Recurring
Description

Neolytica operates as a SaaS-based KOL mapping platform provider for pharmaceutical companies. The platform is sold as a subscription service to pharmaceutical and life sciences organizations for KOL identification, mapping, and engagement measurement.

neolytica.ai
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise SaaS platform for pharmaceutical companies
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing not publicly disclosed. The platform is sold to pharmaceutical and life sciences organizations through direct enterprise sales.

neolytica.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Ti Expert
Description

Platform providing comprehensive data about Key Opinion Leaders, Community Opinion Leaders, and their promotional activities and spheres of influence.

neolytica.ai
+2 more records
Core offering1 text field

Neolytica sells an AI-driven SaaS healthcare analytics platform that helps pharmaceutical and life sciences organizations identify, map, and engage Key Opinion Leaders (KOLs) and Health Care Professionals (HCPs). The platform combines AI/ML and NLP with 300+ medical experts for sentiment analysis across 100,000+ digital platforms, and includes compliance firewalls separating Medical Affairs and Commercial Marketing use cases. Its core products are Ti Expert (KOL mapping and engagement planning) and NotifyMe (real-time social listening and email alerts).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Top 10% of KOLs identified through AI-driven approach impact 60% of target demographics
+1 more record
Product overview1 text field

Neolytica is a healthcare analytics company offering a unified SaaS platform for KOL mapping and HCP engagement. The core platform combines Ti Expert for comprehensive expert identification and engagement planning with NotifyMe for real-time social listening and alerting. These products work together to help pharmaceutical and life science organizations identify Key Opinion Leaders (KOLs), Digital Opinion Leaders (DOLs), and local healthcare influencers, track their sentiment and behavior, and drive personalized engagement strategies. The platform serves Medical Affairs, Market Access, Commercial Marketing, and Commercial Sales teams with compliant firewalls between functions.

Product and service3 records
1Ti Expert
CategoryKOL mapping and HCP engagement platform
Description

Ti Expert is a KOL mapping and expert engagement platform for pharmaceutical and life sciences companies. It provides comprehensive data about validated medical professionals including professional spheres of influence, social relationships, and promotional activities. Features include KOL influence mapping and engagement planning, gap analysis, landscape analysis, message mapping, and identification of rising stars and bridge builders.

2NotifyMe
CategorySocial listening and alerting service
Description

NotifyMe is a healthcare KOL engagement service with email alerts that enables enterprise-scale social listening and provides actionable alerts on healthcare stakeholders in a desired therapeutic area. It offers sentiment tracking, multiple data source screening, and combines technology with human intelligence to provide snapshots of latest and upcoming information on KOLs of interest.

3Ti Risk
CategoryOpioid diversion risk identification platform
Description

Ti Risk is a platform that identifies prescribers and patients who may be involved in the diversion of opioids, designed for pharmaceutical companies operating in controlled substance therapeutic areas.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

QPharma is the parent company of Neolytica. Founded in 1994, QPharma is an industry leader in cloud-based software and services for life sciences, providing solutions including sample management, product launch management, online training, and HCP/KOL targeting and engagement. Neolytica operates as a subsidiary, filling a gap in the industry by creating a single platform for Medical, Marketing, and Commercial teams.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Aktana offers AI-driven commercial engagement and next-best-action intelligence for life sciences, overlapping with Neolytica's Next Best Dialogue feature and AI-driven personalization for pharma field teams.

TypeDirect peer
Description

Within3 is a dedicated KOL and HCP engagement platform for pharma and life sciences, offering virtual advisory boards, stakeholder insights, and engagement analytics that directly compete with Neolytica's Ti Expert and NotifyMe solutions for Medical Affairs and Commercial Marketing buyers.

TypeBroad incumbent
Description

Informa Pharma Intelligence provides broad pharma data, clinical trial, and KOL intelligence products that compete with portions of Neolytica's data aggregation, especially around publications, trials, and expert profiling.

4Monocl
TypeDirect peer
Description

Monocl provides expert profile data and KOL analytics for the life sciences industry, including publication, grant, and clinical trial intelligence. It competes directly with Neolytica's data aggregation capabilities across scientific publications and conferences.

TypeDirect peer
Description

Alpha Sophia is an HCP intelligence platform offering clinician profiling, referral pattern analysis, and KOL mapping for pharma commercial teams, directly overlapping with Neolytica's Rx data, referral pattern, and HCP targeting use cases.

6H1
TypeDirect peer
Description

H1 is a healthcare professional data platform providing expert profiles, KOL identification, and clinical trial investigator insights that directly overlap with Neolytica's expert mapping and sentiment analytics for pharmaceutical customers.

TypeEmerging player
Description

Komodo Health provides healthcare data and analytics, including patient journey, HCP, and claims-based insights for life sciences, with partial overlap to Neolytica's Rx data, referral pattern, and patient journey capabilities.

TypeDirect peer
Description

Veeva is the dominant cloud-based CRM and KOL management platform for the life sciences industry and is directly comparable to Neolytica's Ti Expert platform. The founder Badal Shah previously helped build Veeva's KOL mapping business, underscoring the direct competitive overlap in pharma KOL/HCP engagement software.

TypeBroad incumbent
Description

Definitive Healthcare offers healthcare commercial intelligence including HCP, hospital, and KOL data for life sciences companies. It is a broader incumbent competing with Neolytica in HCP targeting and commercial analytics.

TypeBroad incumbent
Description

IQVIA is a global life sciences services and technology incumbent offering broad commercial analytics, KOL identification, and HCP engagement solutions that overlap with Neolytica but serve a much wider portfolio of pharma and provider clients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Neolytica

Healthcare Analytics / Pharmaceutical KOL Intelligence Softwareneolytica.ai

Neolytica is an AI-driven healthcare analytics subsidiary of QPharma that sells enterprise SaaS for KOL mapping, HCP engagement, and expert-validated sentiment analysis to pharmaceutical Medical Affairs and Commercial teams.

What Neolytica does

Neolytica is a privately held healthcare analytics company that builds AI-driven KOL mapping, HCP engagement, and sentiment analysis software for pharmaceutical and life sciences clients. Founded in March 2022 as a subsidiary of QPharma (established 1994) and headquartered in Morristown, NJ, the company sells two core products under the Ti Expert and NotifyMe brands, plus a Ti Risk module for opioid diversion detection. The platform combines AI/NLP processing of publications, clinical trials, conference proceedings, and social media across 100,000+ digital sources with human review by 300+ medical experts to deliver customized (not syndicated) expert databases, influence mapping, gap and landscape analyses, and a Next Best Dialogue recommendation layer that suggests personalized engagement actions.

Underlying technology spans text NLP, structured claims/Rx analysis, and multimodal expert-profile aggregation. Capabilities include sentiment tagging (Positive/Neutral/Negative), predictive identification of rising-star and bridge-builder KOLs, Influencer Relationship Management with automated compliance workflows, and multi-source social listening via the NotifyMe alerting service. Operations run across the US and India, and the platform already monitors data sources in markets including China. Neolytica monetizes through annual subscription enterprise SaaS contracts sold via direct field sales, with quote-based pricing not publicly disclosed.

The company targets Medical Affairs, Market Access, Commercial Marketing, and Commercial Sales teams within pharmaceutical organizations, and claims 12 of the top 20 pharmaceutical companies as customers. The single-team platform includes compliance firewalls separating Medical and Marketing use, addressing pharma's regulatory constraints. Leadership is anchored by Founder and President Badal Shah, who previously built the KOL mapping business at Veeva Systems. The firm has received recognition including Silicon India 'Most Promising Company' and IFAH Top 100 Healthcare Leader. No external funding rounds are disclosed, consistent with its operating-subsidiary status under QPharma.

Neolytica firmographics

Firmographics
Name
Neolytica
Legal name
Neolytica
Website
https://neolytica.ai
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Neolytica is an AI-driven healthcare analytics subsidiary of QPharma that sells enterprise SaaS for KOL mapping, HCP engagement, and expert-validated sentiment analysis to pharmaceutical Medical Affairs and Commercial teams.
Ownership category
akta.pro rank

Neolytica industry classification

Industry
Product category
Healthcare Analytics / Pharmaceutical KOL Intelligence Software
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • KOL mapping software
  • HCP engagement platform
  • Pharmaceutical analytics
  • Sentiment analysis
  • Healthcare AI platform

Where Neolytica is headquartered

Location

Headquarters

HQ city
Morristown
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Neolytica business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. SaaS Platform Subscriptions: Neolytica operates as a SaaS-based KOL mapping platform provider for pharmaceutical companies. The platform is sold as a subscription service to pharmaceutical and life sciences organizations for KOL identification, mapping, and engagement measurement.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS platform for pharmaceutical companies

Go-to-market motion2 records

Distribution channels1 record

Marketing channels9 records

Neolytica product offering

Product offering

Core offering

Neolytica sells an AI-driven SaaS healthcare analytics platform that helps pharmaceutical and life sciences organizations identify, map, and engage Key Opinion Leaders (KOLs) and Health Care Professionals (HCPs). The platform combines AI/ML and NLP with 300+ medical experts for sentiment analysis across 100,000+ digital platforms, and includes compliance firewalls separating Medical Affairs and Commercial Marketing use cases. Its core products are Ti Expert (KOL mapping and engagement planning) and NotifyMe (real-time social listening and email alerts).

Product overview

Neolytica is a healthcare analytics company offering a unified SaaS platform for KOL mapping and HCP engagement. The core platform combines Ti Expert for comprehensive expert identification and engagement planning with NotifyMe for real-time social listening and alerting. These products work together to help pharmaceutical and life science organizations identify Key Opinion Leaders (KOLs), Digital Opinion Leaders (DOLs), and local healthcare influencers, track their sentiment and behavior, and drive personalized engagement strategies. The platform serves Medical Affairs, Market Access, Commercial Marketing, and Commercial Sales teams with compliant firewalls between functions.

Differentiator

Problem solved

Functional benefit

Brands

  • Ti Expert: Platform providing comprehensive data about Key Opinion Leaders, Community Opinion Leaders, and their promotional activities and spheres of influence.
  • NotifyMe
  • Ti Risk

Products and services

  • Ti Expert Ti Expert is a KOL mapping and expert engagement platform for pharmaceutical and life sciences companies. It provides comprehensive data about validated medical professionals including professional spheres of influence, social relationships, and promotional activities. Features include KOL influence mapping and engagement planning, gap analysis, landscape analysis, message mapping, and identification of rising stars and bridge builders.
  • NotifyMe NotifyMe is a healthcare KOL engagement service with email alerts that enables enterprise-scale social listening and provides actionable alerts on healthcare stakeholders in a desired therapeutic area. It offers sentiment tracking, multiple data source screening, and combines technology with human intelligence to provide snapshots of latest and upcoming information on KOLs of interest.
  • Ti Risk Ti Risk is a platform that identifies prescribers and patients who may be involved in the diversion of opioids, designed for pharmaceutical companies operating in controlled substance therapeutic areas.

Quantifiable outcome

  • Top 10% of KOLs identified through AI-driven approach impact 60% of target demographics
  • +1 more outcomes

Companies that use Neolytica

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Neolytica technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature5 records

Neolytica partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • QPharmacoreStrategic or Co-development PartnerQPharma is the parent company of Neolytica. Founded in 1994, QPharma is an industry leader in cloud-based software and services for life sciences, providing solutions including sample management, product launch management, online training, and HCP/KOL targeting and engagement. Neolytica operates as a subsidiary, filling a gap in the industry by creating a single platform for Medical, Marketing, and Commercial teams.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Neolytica competitors and assessment

Company assessment

Emerging players

  • Aktana: Aktana offers AI-driven commercial engagement and next-best-action intelligence for life sciences, overlapping with Neolytica's Next Best Dialogue feature and AI-driven personalization for pharma field teams.
  • Komodo Health: Komodo Health provides healthcare data and analytics, including patient journey, HCP, and claims-based insights for life sciences, with partial overlap to Neolytica's Rx data, referral pattern, and patient journey capabilities.

Direct peers

  • Within3: Within3 is a dedicated KOL and HCP engagement platform for pharma and life sciences, offering virtual advisory boards, stakeholder insights, and engagement analytics that directly compete with Neolytica's Ti Expert and NotifyMe solutions for Medical Affairs and Commercial Marketing buyers.
  • Monocl: Monocl provides expert profile data and KOL analytics for the life sciences industry, including publication, grant, and clinical trial intelligence. It competes directly with Neolytica's data aggregation capabilities across scientific publications and conferences.
  • Alpha Sophia: Alpha Sophia is an HCP intelligence platform offering clinician profiling, referral pattern analysis, and KOL mapping for pharma commercial teams, directly overlapping with Neolytica's Rx data, referral pattern, and HCP targeting use cases.
  • H1: H1 is a healthcare professional data platform providing expert profiles, KOL identification, and clinical trial investigator insights that directly overlap with Neolytica's expert mapping and sentiment analytics for pharmaceutical customers.
  • Veeva Systems: Veeva is the dominant cloud-based CRM and KOL management platform for the life sciences industry and is directly comparable to Neolytica's Ti Expert platform. The founder Badal Shah previously helped build Veeva's KOL mapping business, underscoring the direct competitive overlap in pharma KOL/HCP engagement software.

Broad incumbents

  • Informa Pharma Intelligence: Informa Pharma Intelligence provides broad pharma data, clinical trial, and KOL intelligence products that compete with portions of Neolytica's data aggregation, especially around publications, trials, and expert profiling.
  • Definitive Healthcare: Definitive Healthcare offers healthcare commercial intelligence including HCP, hospital, and KOL data for life sciences companies. It is a broader incumbent competing with Neolytica in HCP targeting and commercial analytics.
  • IQVIA: IQVIA is a global life sciences services and technology incumbent offering broad commercial analytics, KOL identification, and HCP engagement solutions that overlap with Neolytica but serve a much wider portfolio of pharma and provider clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Neolytica social profiles

Digital presence

Neolytica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Neolytica leadership team

Management profile

Number of profiles

Profiles1 record

Neolytica funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Neolytica M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neolytica

What does Neolytica do?

Neolytica sells an AI-driven SaaS healthcare analytics platform that helps pharmaceutical and life sciences organizations identify, map, and engage Key Opinion Leaders (KOLs) and Health Care Professionals (HCPs). The platform combines AI/ML and NLP with 300+ medical experts for sentiment analysis across 100,000+ digital platforms, and includes compliance firewalls separating Medical Affairs and Commercial Marketing use cases. Its core products are Ti Expert (KOL mapping and engagement planning) and NotifyMe (real-time social listening and email alerts).

Is Neolytica a public or private company?

Neolytica is a private company. It is classified as corporate owned and is currently operating.

When was Neolytica founded?

Neolytica was founded in 2022. It employs 11 to 50 people.

Where is Neolytica based?

Neolytica is headquartered in Morristown, United States, in the North America region.

How does Neolytica make money?

One revenue line is on record: saaS Platform Subscriptions.

Who are Neolytica's main competitors?

Emerging players on record are Aktana and Komodo Health. Direct peers are Within3, Monocl, Alpha Sophia, H1 and Veeva Systems. Broad incumbents are Informa Pharma Intelligence, Definitive Healthcare and IQVIA.

Does Neolytica have an API?

No public API is recorded for Neolytica.

What industry is Neolytica in?

Neolytica's product category is Healthcare Analytics / Pharmaceutical KOL Intelligence Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals